MUST READ...VANCOUVER, Washington, Jan. 03, 2017 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that management will hold an investment community conference call on Thursday, January 5, 2017, at 1:00 p.m. PT / 4:00 p.m. ET to provide an update on clinical trial and regulatory developments.
Management also announces that it will post a “Letter to Shareholders and Friends” from President and CEO Nader Pourhassan Ph.D. reviewing the Company’s progress and highlighting 2017 milestones to its corporate website at www.cytodyn.com on Thursday, January 5, 2017.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.